Kirwin Patrick D.Director
Buy $45.3K of disclosed value in ProMIS Neurosciences, Inc. $PMN.
Buy
GLP-1 & Metabolic Health
Last updated
Jul 3, 2026
Based on
222 actions
Gurus considered
149
Stocks covered
170
Obesity, diabetes, GLP-1, and metabolic disease exposure. This page tracks 222 investor, Congress, and insider actions tied to GLP-1 & Metabolic Health within Healthcare Innovation, connecting the industry classification with the people and institutions currently showing activity. It gives context from 149 gurus across 170 stocks, so the feed can be read as an industry-level signal rather than a loose list of single-stock events.
GLP-1 & Metabolic Health Smart Money Notes
Baillie Gifford
Trim transactions in TransMedics Group, Inc. $TMDX and Insulet Corp $PODD.
Trim
Ball Titus B.PAO
Sell $30.9K of disclosed value in BeOne Medicines Ltd. $ONC.
Sell
Ken Fisher
Trim transactions in Eli Lilly and Company Common Stock $LLY and Novo Nordisk A/S $NVO.
Trim
Gill JohnDirector
Buy $31.4K of disclosed value in Altimmune, Inc. $ALT.
Buy
Bessler RobertDirector
Sell $35.8K of disclosed value in LifeStance Health Group, Inc. $LFST.
Sell
Andreas Halvorsen
Add $103.2M of disclosed value in Pharvaris N.V. $PHVS.
Add
Jim Simons
Trim $66.0M of disclosed value in Eli Lilly and Company Common Stock $LLY.
Trim
Sands Capital
Exit $-301.6M of disclosed value in iRhythm Technologies, Inc. $IRTC.
Exit
Tweedy Browne
Add $10.9M of disclosed value in Novartis AG Common Stock $NVS.
Add
Tom Gayner
Trim $105.5M of disclosed value in Novo Nordisk A/S $NVO.
Trim
Ken Fisher
Add $2.1B of disclosed value in Novartis AG Common Stock $NVS.
Add
Showing 211-222 of 222